Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 42 studies | 37% ± 15% | |
fibroblast | 34 studies | 32% ± 11% | |
pericyte | 34 studies | 38% ± 17% | |
macrophage | 32 studies | 29% ± 11% | |
astrocyte | 23 studies | 54% ± 18% | |
conventional dendritic cell | 21 studies | 32% ± 14% | |
classical monocyte | 19 studies | 25% ± 10% | |
oligodendrocyte | 17 studies | 63% ± 14% | |
dendritic cell | 16 studies | 38% ± 21% | |
microglial cell | 15 studies | 41% ± 15% | |
monocyte | 14 studies | 27% ± 10% | |
endothelial cell of lymphatic vessel | 14 studies | 29% ± 10% | |
smooth muscle cell | 14 studies | 22% ± 6% | |
oligodendrocyte precursor cell | 14 studies | 44% ± 17% | |
capillary endothelial cell | 14 studies | 33% ± 8% | |
glutamatergic neuron | 13 studies | 67% ± 19% | |
vein endothelial cell | 13 studies | 32% ± 10% | |
type I pneumocyte | 12 studies | 40% ± 11% | |
GABAergic neuron | 11 studies | 57% ± 21% | |
endothelial cell of artery | 11 studies | 30% ± 8% | |
type II pneumocyte | 10 studies | 25% ± 12% | |
connective tissue cell | 10 studies | 23% ± 5% | |
neuron | 10 studies | 60% ± 13% | |
endothelial cell of vascular tree | 10 studies | 27% ± 6% | |
plasmacytoid dendritic cell | 10 studies | 30% ± 11% | |
myeloid cell | 9 studies | 30% ± 13% | |
non-classical monocyte | 8 studies | 26% ± 10% | |
myofibroblast cell | 8 studies | 24% ± 8% | |
amacrine cell | 8 studies | 44% ± 17% | |
epithelial cell | 7 studies | 22% ± 6% | |
interneuron | 7 studies | 64% ± 17% | |
retinal ganglion cell | 7 studies | 84% ± 17% | |
alveolar macrophage | 6 studies | 24% ± 5% | |
mononuclear phagocyte | 6 studies | 29% ± 8% | |
retina horizontal cell | 6 studies | 45% ± 15% | |
Mueller cell | 6 studies | 46% ± 15% | |
goblet cell | 5 studies | 30% ± 13% | |
glial cell | 5 studies | 37% ± 8% | |
adventitial cell | 5 studies | 27% ± 8% | |
glomerular endothelial cell | 4 studies | 47% ± 5% | |
abnormal cell | 4 studies | 30% ± 15% | |
granule cell | 4 studies | 50% ± 5% | |
GABAergic amacrine cell | 4 studies | 49% ± 17% | |
mesothelial cell | 4 studies | 23% ± 6% | |
brush cell | 4 studies | 35% ± 19% | |
enteroendocrine cell | 4 studies | 23% ± 9% | |
club cell | 4 studies | 20% ± 6% | |
retinal bipolar neuron | 3 studies | 36% ± 11% | |
GABAergic interneuron | 3 studies | 62% ± 8% | |
progenitor cell | 3 studies | 33% ± 6% | |
retinal cone cell | 3 studies | 29% ± 3% | |
adipocyte | 3 studies | 17% ± 1% | |
tissue-resident macrophage | 3 studies | 22% ± 3% | |
OFF-bipolar cell | 3 studies | 59% ± 29% | |
ON-bipolar cell | 3 studies | 55% ± 32% | |
glycinergic amacrine cell | 3 studies | 30% ± 9% | |
rod bipolar cell | 3 studies | 40% ± 11% | |
endothelial cell of sinusoid | 3 studies | 34% ± 17% | |
neural progenitor cell | 3 studies | 51% ± 21% | |
ependymal cell | 3 studies | 59% ± 18% | |
Schwann cell | 3 studies | 49% ± 20% | |
melanocyte | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 21 studies | 55% ± 20% | |
lung | 10 studies | 23% ± 4% | |
eye | 10 studies | 27% ± 11% | |
heart | 5 studies | 19% ± 2% | |
intestine | 3 studies | 23% ± 7% | |
peripheral blood | 3 studies | 25% ± 4% | |
uterus | 3 studies | 21% ± 4% | |
adipose | 3 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 32874.31 | 2641 / 2642 | 100% | 333.33 | 704 / 705 |
breast | 100% | 11484.80 | 459 / 459 | 92% | 43.80 | 1031 / 1118 |
lung | 100% | 18298.25 | 578 / 578 | 88% | 51.03 | 1012 / 1155 |
adrenal gland | 95% | 6693.02 | 246 / 258 | 90% | 77.86 | 206 / 230 |
skin | 88% | 5461.74 | 1597 / 1809 | 92% | 72.52 | 435 / 472 |
intestine | 94% | 8018.21 | 905 / 966 | 87% | 41.07 | 456 / 527 |
ovary | 100% | 8523.66 | 180 / 180 | 75% | 29.13 | 321 / 430 |
thymus | 96% | 5503.10 | 624 / 653 | 79% | 23.66 | 475 / 605 |
kidney | 74% | 3348.04 | 66 / 89 | 90% | 77.48 | 810 / 901 |
esophagus | 73% | 6044.45 | 1054 / 1445 | 89% | 37.29 | 162 / 183 |
uterus | 99% | 6385.00 | 168 / 170 | 63% | 24.97 | 287 / 459 |
bladder | 90% | 8107.67 | 19 / 21 | 59% | 25.62 | 297 / 504 |
stomach | 48% | 3359.29 | 171 / 359 | 90% | 42.19 | 256 / 286 |
prostate | 79% | 4362.15 | 193 / 245 | 48% | 11.67 | 242 / 502 |
pancreas | 5% | 199.06 | 18 / 328 | 96% | 55.55 | 170 / 178 |
adipose | 100% | 13158.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8811.49 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 7947.41 | 845 / 861 | 0% | 0 | 0 / 0 |
spleen | 93% | 5007.48 | 225 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 32.96 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 80% | 33.76 | 36 / 45 |
eye | 0% | 0 | 0 / 0 | 45% | 18.46 | 36 / 80 |
liver | 6% | 202.85 | 13 / 226 | 38% | 14.65 | 156 / 406 |
muscle | 18% | 660.54 | 146 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 198.31 | 52 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
GO_0007165 | Biological process | signal transduction |
GO_0007399 | Biological process | nervous system development |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0030154 | Biological process | cell differentiation |
GO_0006897 | Biological process | endocytosis |
GO_0006208 | Biological process | pyrimidine nucleobase catabolic process |
GO_0005874 | Cellular component | microtubule |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004157 | Molecular function | dihydropyrimidinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0016812 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
Gene name | DPYSL2 |
Protein name | Dihydropyrimidinase-like 2 short form Dihydropyrimidinase like 2 Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2) Dihydropyrimidinase-related protein 2 Dihydropyrimidinase-like 2 long form |
Synonyms | CRMP2 ULIP2 |
Description | FUNCTION: Plays a role in neuronal development and polarity, as well as in axon growth and guidance, neuronal growth cone collapse and cell migration. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. May play a role in endocytosis. . FUNCTION: Plays a role in neuronal development and polarity, as well as in axon growth and guidance, neuronal growth cone collapse and cell migration. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. May play a role in endocytosis. . |
Accessions | A9CQZ4 ENST00000493789.6 ENST00000521913.7 ENST00000311151.9 [Q16555-1] Q16555 E5RFU4 A9CQZ2 ENST00000523027.1 [Q16555-2] A0A1C7CYX9 |